Accessing GLP-1 treatment in Millbrae, California has traditionally meant longer waits than mainland patients face. Ozempic® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Millbrae address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Ozempic prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Millbrae is already seeing results
Ozempic in Millbrae, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Ozempic to patients in Millbrae from $199/month with virtual consultations and direct-to-door shipping.
Ozempic® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2017 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Millbrae residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Millbrae's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Ozempic® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk since 2017. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Semaglutide delivered to your Millbrae address at $199/month. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.